Inspire Medical Systems ROE 2017-2024 | INSP
Current and historical return on equity (ROE) values for Inspire Medical Systems (INSP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Inspire Medical Systems ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $0.03B | $0.70B | 5.29% |
| 2024-06-30 | $0.01B | $0.64B | 1.02% |
| 2024-03-31 | $-0.02B | $0.59B | -2.86% |
| 2023-12-31 | $-0.02B | $0.57B | -3.91% |
| 2023-09-30 | $-0.03B | $0.54B | -6.36% |
| 2023-06-30 | $-0.04B | $0.53B | -8.20% |
| 2023-03-31 | $-0.04B | $0.51B | -10.13% |
| 2022-12-31 | $-0.05B | $0.50B | -12.69% |
| 2022-09-30 | $-0.05B | $0.47B | -17.38% |
| 2022-06-30 | $-0.04B | $0.23B | -19.09% |
| 2022-03-31 | $-0.04B | $0.23B | -18.79% |
| 2021-12-31 | $-0.04B | $0.23B | -18.39% |
| 2021-09-30 | $-0.05B | $0.22B | -20.60% |
| 2021-06-30 | $-0.05B | $0.22B | -20.40% |
| 2021-03-31 | $-0.06B | $0.22B | -24.45% |
| 2020-12-31 | $-0.06B | $0.23B | -27.32% |
| 2020-09-30 | $-0.06B | $0.23B | -31.78% |
| 2020-06-30 | $-0.06B | $0.23B | -34.62% |
| 2020-03-31 | $-0.04B | $0.13B | -29.03% |
| 2019-12-31 | $-0.03B | $0.14B | -22.18% |
| 2019-09-30 | $-0.03B | $0.15B | -18.74% |
| 2019-06-30 | $-0.03B | $0.15B | -18.21% |
| 2019-03-31 | $-0.02B | $0.16B | -18.39% |
| 2018-12-31 | $-0.02B | $0.16B | -25.56% |
| 2018-09-30 | $-0.02B | $0.10B | -44.67% |
| 2018-06-30 | $-0.02B | $0.10B | -84.85% |
| 2018-03-31 | $-0.02B | $-0.01B | 2000.00% |
| 2017-12-31 | $-0.02B | $0.00B | -6800.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.276B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.497B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
| Privia Health (PRVA) | United States | $2.533B | 211.10 |
| Enovis (ENOV) | United States | $2.529B | 17.15 |
| IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
| Azenta (AZTA) | United States | $2.001B | 99.78 |
| Omnicell (OMCL) | United States | $1.964B | 64.26 |
| Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
| 10x Genomics (TXG) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.378B | 0.00 |
| Phreesia (PHR) | United States | $1.072B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Standard BioTools (LAB) | United States | $0.562B | 0.00 |
| Talkspace (TALK) | United States | $0.522B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
| Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
| TruBridge (TBRG) | United States | $0.244B | 71.22 |
| Pulmonx (LUNG) | United States | $0.237B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
| American Well (AMWL) | United States | $0.122B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Outset Medical (OM) | United States | $0.039B | 0.00 |
| Movano (MOVE) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |